Drug Profile
Research progamme: antibody-drug conjugates - PhotoBiotics/Quassia Biopharma
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator PhotoBiotics
- Class Antibodies; Drug conjugates; Immunoconjugates
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Unspecified in United Kingdom (Parenteral)
- 28 Jul 2016 Early research in Undefined indication in United Kingdom (Parenteral)